Perfusion System Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Perfusion systems are specialized medical devices that pump blood or preservation fluid through tissues and organs during surgical procedures or ex-vivo storage. The global market, estimated at $2.86 billion in 2025, encompasses equipment used in cardiopulmonary bypass during open-heart surgery, organ preservation for transplantation, and laboratory research applications.

• •Used primarily in cardiac surgery, organ transplantation, and extracorporeal membrane oxygenation (ECMO)
• •Market includes hardware components such as heart-lung machines, oxygenators, and preservation consoles
• •Driven by rising cardiovascular disease incidence and growing demand for organ transplants globally

The market's 7.8% annual growth rate reflects several converging healthcare trends. Increasing volumes of cardiac surgical procedures, an aging global population with higher rates of heart disease, and rising organ transplant registrations are primary demand drivers. Technological innovations in normothermic machine perfusion, which preserves organs at body temperature rather than on ice, are expanding clinical applications and improving transplant outcomes.

• •Rising prevalence of cardiovascular diseases and increasing cardiac surgery volumes worldwide
• •Growing demand for organ transplantation and advancements in ex-vivo organ perfusion technology
• •Technological improvements in machine perfusion systems, including normothermic and hypothermic techniques

The market is segmented by system type, including cardiopulmonary bypass devices, organ preservation systems, and research-grade perfusion equipment, and by technology, with machine perfusion emerging as a key growth sub-segment. North America and Europe currently represent the largest regional markets, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement frameworks.

• •North America leads the market due to high healthcare spending, advanced medical infrastructure, and strong cardiac surgery volumes
• •Europe and the Asia-Pacific region are experiencing significant growth, with Asia-Pacific benefiting from improving healthcare access and rising medical tourism
• •Product segmentation includes cardiopulmonary bypass systems, organ preservation devices, and hypothermic/normothermic perfusion machines

What are the recent trends and outlook?

The market is trending toward minimally invasive surgical techniques, portable and modular perfusion systems, and the integration of real-time monitoring and data analytics capabilities. Normothermic machine perfusion is rapidly gaining adoption for lung, liver, and heart preservation, offering improved graft viability and expanded donor organ utilization. Over the forecast period, continued R&D investment, expanding indications, and healthcare system investment in transplantation infrastructure are expected to sustain strong market momentum.

• •Normothermic machine perfusion is transforming organ preservation, enabling longer transport times and improved transplant outcomes
• •Emerging markets in Asia-Pacific, Latin America, and the Middle East present significant growth opportunities as healthcare infrastructure expands
• •Integration of digital monitoring, artificial intelligence, and robotics is expected to drive the next generation of perfusion system innovation